Trending Topics in Gastroenterology | GastroAGI

Early-Onset Pancreatic Cancer Shows Aggressive Molecular Biology : Br J Surg | May 2026

Introduction The global rise in early-onset gastrointestinal malignancies has become a major oncologic concern, with pancreatic ductal adenocarcinoma (PDAC) increasingly being diagnosed in patients younger than 50 years. Although younger patients are generally presumed to tolerate aggressive multimodality treatment better, the biological behavior of early-onset pancreatic cancer (EOPC) remains poorly understood. Problem Statement Existing studies evaluating outcomes in EOPC have produced conflicting results, and the molecular mechanisms underlying disease aggressiveness in younger patients remain unclear. Whether EOPC differs biologically from late-onset PDAC has important implications for prognosis, surveillance and therapeutic decision-making. Summary This large multicenter translational study demonstrated that surgically resected EOPC is associated with significantly earlier postoperative recurrence and more aggressive molecular characteristics compared with late-onset PDAC. Despite receiving adjuvant chemotherapy more frequently and completing treatment more often than older patients, individuals with EOPC experienced shorter disease-free survival and remained at increased risk of recurrence after resection. Importantly, these poorer outcomes could not be explained by conventional clinicopathological factors such as tumor stage, nodal burden, margin status or differentiation grade. Transcriptomic analysis revealed enrichment of squamous (basal-like) molecular subtype signatures in EOPC, including increased expression of aggressive genes such as S100A2, TP63 and MYC-related proliferative pathways, alongside downregulation of GATA6, a marker associated with the more favorable classical pancreatic subtype. Gene programs linked to cell proliferation, squamous differentiation, inflammation and metabolic reprogramming were significantly enriched in younger patients, supporting a biologically aggressive phenotype. Additionally, immune-related gene pathways appeared relatively suppressed in EOPC, although major differences in immune cell infiltration were not definitively demonstrated. Germline mutations were not more common in younger patients, suggesting that inherited predisposition alone does not explain disease biology. Collectively, the findings challenge the assumption that younger age predicts favorable pancreatic cancer outcomes and instead support EOPC as a distinct high-risk biological subtype that may require intensified surveillance, earlier systemic therapy optimization and prioritization for biomarker-driven clinical trials.

Financial Toxicity After Complex GI Surgery : Ann Surg | May 2026

Introduction Financial toxicity (FT) has emerged as an important yet underrecognized consequence of modern cancer care. Patients undergoing major gastrointestinal (GI) surgery frequently face substantial economic stress related to hospitalization, prolonged recovery, loss of income and ongoing medical expenses. Although FT has been studied in oncology, its impact in complex GI surgical populations and its relationship with patient-reported quality-of-life outcomes remain insufficiently explored. Problem Statement Patients undergoing pancreatic, hepatobiliary and other complex GI procedures often experience prolonged treatment pathways involving multimodal therapy and intensive postoperative care. However, limited data exist regarding the prevalence of FT in GI surgery and its influence on emotional and social well-being. Better identification of vulnerable patients is essential to enable timely financial and psychosocial support interventions. Summary This prospective study evaluated FT among patients undergoing major GI surgery using validated patient-reported outcome instruments. Nearly one-third of patients experienced clinically significant FT, highlighting the substantial economic burden associated with complex surgical care. Pancreatic resections constituted the largest subgroup, reflecting the intensive treatment requirements of these patients. Importantly, FT demonstrated a meaningful association with emotional and social well-being, emphasizing that financial strain extends beyond economic hardship and directly affects overall quality of life. Single marital status emerged as an independent predictor of FT, suggesting that limited social support networks may increase vulnerability to financial distress. Interestingly, patients not receiving chemotherapy or radiation therapy also showed higher odds of FT, potentially reflecting differences in insurance coverage, employment disruption or access to coordinated oncologic care. The study reinforces the growing recognition that financial health represents a critical component of perioperative outcomes. The authors propose that preoperative identification of high-risk patients may facilitate early referral to financial counseling, social work and supportive care services. Overall, this work highlights FT as a clinically relevant and measurable postoperative burden in GI surgery, supporting the integration of financial risk assessment into multidisciplinary surgical oncology care pathways.

Minimally Invasive Surgery Provides Durable Relief in Thoracic Esophageal Diverticula : Journal of Gastrointestinal Surgery | May 2026

Introduction Mid- and distal thoracic esophageal diverticula are uncommon but clinically significant disorders that frequently present with dysphagia, regurgitation and aspiration-related symptoms. Surgical management has evolved substantially over the past two decades, with minimally invasive approaches increasingly replacing traditional thoracotomy-based procedures to reduce perioperative morbidity while maintaining symptomatic benefit. Problem Statement Despite growing adoption of minimally invasive surgery for thoracic esophageal diverticula, long-term outcome data remain limited because of the rarity of the condition and the heterogeneity of operative strategies. Questions persist regarding durability of symptom relief, recurrence rates and the importance of adjunctive esophageal myotomy in optimizing postoperative outcomes. Summary This large single-center experience demonstrates that minimally invasive surgery is an effective and safe treatment strategy for symptomatic mid- to distal thoracic esophageal diverticula. Most patients presented with clinically significant dysphagia, and underlying esophageal motility disorders—particularly achalasia—were frequently identified, supporting the concept that diverticula are often secondary to functional outflow abnormalities. Minimally invasive thoracoscopic and laparoscopic approaches achieved excellent symptomatic improvement, with nearly 90% of patients reporting complete resolution of dysphagia early after surgery. Although some patients experienced recurrent or residual symptoms during longer follow-up, overall dysphagia severity remained substantially improved compared with preoperative status. The study also highlights the importance of concomitant myotomy, which was performed in most patients and likely contributed to favorable functional outcomes by addressing the underlying motility disorder. Postoperative esophageal leak remained the most important complication, although rates were acceptable and mortality was absent. Importantly, only a minority of patients with recurrent diverticula required reoperation, suggesting that radiographic recurrence does not necessarily correlate with clinically significant failure. Overall, the findings support minimally invasive surgery as the preferred approach for symptomatic thoracic esophageal diverticula, providing durable symptom relief with relatively low morbidity in experienced centers.

Robotic Groin Hernia Repair Shows No Long-Term Recurrence Advantage | JAMA Surgery

Introduction Robotic-assisted groin hernia repair has rapidly expanded across surgical practice in the United States, driven by increasing adoption of minimally invasive techniques and perceived technical advantages such as enhanced visualization and improved surgeon ergonomics. Despite this growth, robust population-level evidence comparing long-term outcomes of robotic, laparoscopic and open approaches remains limited. Problem Statement Although robotic surgery is increasingly used for groin hernia repair, it remains unclear whether this technology improves long-term durability compared with established laparoscopic and open techniques. Given the substantial costs and rapid dissemination of robotic platforms, understanding whether robotic repair meaningfully reduces recurrence is essential for evaluating its true clinical value. Summary This large Medicare-based cohort study found that robotic-assisted groin hernia repair was associated with slightly higher long-term operative recurrence rates compared with laparoscopic and open approaches, without demonstrating a clinically meaningful advantage in repair durability. Over five years of follow-up, recurrence rates remained low across all surgical techniques, but laparoscopic repair consistently showed the lowest recurrence risk, while robotic-assisted repair demonstrated the highest cumulative recurrence incidence. Importantly, these findings remained stable across multiple sensitivity analyses, including elective versus emergent repairs, unilateral versus bilateral procedures and varying levels of surgeon robotic utilization. The study highlights the rapid expansion of robotic-assisted hernia surgery despite limited evidence of superior long-term outcomes and raises important questions regarding technology adoption driven more by market forces and procedural diffusion than by demonstrable clinical benefit. The authors emphasize that recurrence rates alone may not fully capture the value of robotic surgery and suggest that future evaluation should incorporate broader outcomes such as recovery, conversion rates, patient experience and healthcare utilization. Overall, the findings challenge assumptions that robotic repair offers superior long-term effectiveness for groin hernia surgery and reinforce the need for evidence-based adoption of surgical innovation.

Younger Adults Face Higher Intra-Abdominal Risk After Colectomy for Diverticular Disease | Journal of Gastrointestinal Surgery

Introduction Diverticular disease has traditionally been considered a condition of older adults, but its incidence in younger populations has risen substantially over recent decades. As colectomy is increasingly performed in younger patients with diverticular disease, understanding age-specific postoperative risk has become essential to guide surgical decision making and patient counselling. Problem Statement Younger patients undergoing colectomy for diverticular disease are often perceived as lower-risk surgical candidates because they generally have fewer comorbidities and better overall physiological reserve. However, whether younger age confers a true postoperative advantage remains uncertain, particularly with respect to clinically significant intra-abdominal complications following colectomy. Summary This large national surgical outcomes study challenges the assumption that younger patients experience better postoperative outcomes after colectomy for diverticular disease. Using NSQIP data from nearly 40,000 patients, the authors found that although younger adults had a generally healthier baseline profile, they did not experience lower overall postoperative risk compared with older patients. Notably, age younger than 50 years independently increased the risk of major intra-abdominal complications, including anastomotic leak and organ-space surgical site infection. While older patients had slightly higher readmission rates overall, younger patients who were readmitted returned earlier, suggesting a distinct postoperative risk pattern in this group. These findings indicate that younger age should not be viewed as inherently protective in the perioperative setting and that colectomy in younger patients carries meaningful risk despite fewer traditional comorbidities. The study provides important evidence to support more balanced patient counselling and reinforces the need for individualized surgical decision making rather than age-based assumptions in diverticular disease management.

Robot-Assisted Esophagectomy vs Conventional MIE: Annals of Surgical Oncology | April 2026

Introduction Surgical management of Esophageal cancer continues to evolve, with minimally invasive techniques improving perioperative outcomes. A newer concept—total mesoesophageal excision (TME)—aims to enhance oncologic clearance. The integration of robotic surgery with TME (RATME) is proposed to further refine precision and outcomes compared to conventional minimally invasive esophagectomy (MIE). Problem Statement It remains unclear whether robot-assisted esophagectomy combined with TME offers meaningful advantages over conventional minimally invasive approaches in terms of surgical and oncologic outcomes. Summary This multicenter retrospective study compared robot-assisted TME esophagectomy (RATME) with other minimally invasive approaches. The robotic TME group had longer operative times but demonstrated important perioperative advantages, including reduced blood loss, shorter postoperative hospital stay, and lower complication rates. Additionally, the TME approach resulted in a higher lymph node yield, suggesting improved oncologic clearance. Although overall survival and disease-free survival were not significantly different across groups, trends toward lower recurrence and mortality were observed in the RATME group. The key takeaway is that robot-assisted TME appears to enhance surgical precision and short-term outcomes, with potential long-term benefits. However, the trade-off includes longer operative time, and further studies are needed to confirm survival advantages. Key Takeaways: Better surgery today may translate into better cancer outcomes tomorrow—but stronger evidence is still needed.

Pyloroplasty During MIE/RAMIE: Annals of Surgery | April 2026

Introduction Minimally invasive esophagectomy (MIE) and robot-assisted MIE (RAMIE) are standard approaches in the treatment of Esophageal cancer. One debated step during surgery is whether to perform pyloroplasty, a procedure intended to improve gastric emptying after esophageal resection. Despite widespread use, high-quality evidence supporting or refuting its benefit has been limited, especially in the modern minimally invasive era. Problem Statement There is a lack of level-1 evidence to determine whether adding pyloroplasty during MIE or RAMIE improves postoperative outcomes. Summary This phase III randomized controlled trial provides important evidence supporting the use of pyloroplasty during minimally invasive esophagectomy. The study used an adaptive design and demonstrated that patients undergoing pyloroplasty had better short-term outcomes compared to those without it. The primary composite outcome—pneumonia or anastomotic leak requiring surgery—occurred less frequently in the pyloroplasty group (18%) compared to the no-pyloroplasty group (27%). The trial was stopped early once predefined superiority criteria were met, indicating a high probability that pyloroplasty improves short-term outcomes. Clinically, this suggests that pyloroplasty may reduce postoperative complications, particularly respiratory and anastomotic issues, in patients undergoing MIE or RAMIE. However, long-term outcomes and quality-of-life data are still awaited. Key takeaway: Adding pyloroplasty during minimally invasive esophagectomy improves short-term surgical outcomes and may be considered a beneficial adjunct procedure.

Micronutrients and Thyroid Recovery After Sleeve Gastrectomy: AJS | April 2026

Introduction Bariatric surgery, particularly sleeve gastrectomy, is increasingly recognized not only for weight loss but also for its metabolic benefits, including improvement in endocrine disorders such as hypothyroidism. While many patients experience normalization of thyroid function after surgery, predicting which patients will achieve thyroid-stimulating hormone (TSH) remission remains unclear. Emerging evidence suggests that micronutrient status—especially vitamin D and vitamin B12—may play a role in endocrine recovery and metabolic regulation. Problem Statement There is a lack of reliable preoperative predictors to identify which hypothyroid patients will achieve TSH remission after sleeve gastrectomy. Summary This study demonstrates that preoperative levels of vitamin D and vitamin B12 are strong predictors of TSH remission following sleeve gastrectomy. Patients with higher baseline levels of these micronutrients had significantly higher rates of remission at both 6 and 12 months. Notably, up to 77.5% of patients achieved TSH normalization by 12 months, with many able to reduce or discontinue levothyroxine therapy, and none requiring dose escalation. Importantly, micronutrient levels outperformed traditional predictors such as age, sex, and BMI, highlighting a potentially modifiable factor in preoperative optimization. Both vitamin D and B12 showed strong predictive accuracy, suggesting a clinically meaningful role in patient selection and counseling. From a practical standpoint, this study supports routine assessment and correction of micronutrient deficiencies before bariatric surgery. It also opens the possibility that optimizing nutritional status may enhance endocrine recovery, moving toward a more personalized and proactive perioperative strategy.

Predicting Perineural Invasion in CRC: Surgery | April 2026

Perineural invasion (PNI) is a well-recognized adverse prognostic factor in colorectal cancer (CRC), associated with aggressive tumor biology, higher metastatic potential, and poor survival outcomes. However, PNI is typically identified only after surgical resection on histopathology. The ability to predict PNI preoperatively could significantly influence risk stratification, surgical planning, and decisions regarding neoadjuvant or adjuvant therapy. Problem Statement Currently, there is no reliable preoperative tool to predict perineural invasion in colorectal cancer. This limits the ability to identify high-risk patients early and incorporate this critical prognostic factor into multidisciplinary decision-making before definitive treatment. Summary This large SEER-based case-control study involving over 223,000 CRC patients identified key predictors of PNI, including male sex, tumor location (left colon and rectum), poor differentiation, nodal involvement (N1/N2), and elevated carcinoembryonic antigen levels. PNI was present in 13.1% of cases and was strongly associated with worse 5-year overall and cancer-specific survival, as well as increased liver and lung metastases. The derived Cleveland Clinic Florida PNI prediction score demonstrated excellent negative predictive value (93%), making it particularly useful to rule out PNI preoperatively. This model has potential clinical utility in guiding personalized treatment strategies and improving multidisciplinary planning in colorectal cancer.

Vasculobiliary Injury in Laparoscopic and Open Cholecystectomy HPB | 2026

Introduction Vasculobiliary injury is one of the most serious complications associated with cholecystectomy, particularly when a bile duct injury is accompanied by injury to the hepatic artery or portal vein. These combined injuries are clinically important because vascular compromise can worsen the biliary injury, extend its level, impair healing after reconstruction, and in severe cases lead to liver ischemia, infarction, abscess formation, or hepatic atrophy. This review was undertaken to clarify the definition of vasculobiliary injury, examine its mechanisms, and outline its clinical implications and management. Summary This review defines vasculobiliary injury as a combined injury involving both a bile duct and a hepatic artery and/or portal vein, with the bile duct damage resulting from operative trauma, ischemia, or both. The authors show that the most common form is injury to the right hepatic artery associated with bile duct injury. In these cases, arterial damage may silently worsen the biliary injury by making it extend higher than the gross mechanical injury initially suggests. The review also highlights that right hepatic artery injury rarely causes major problems when isolated, but becomes clinically significant when combined with bile duct injury because collateral blood flow is disrupted. This combination increases the risk of biliary ischemia, anastomotic failure, restricture, and in about 10% of patients, slow infarction of the right liver. Injuries involving the portal vein or the proper or common hepatic artery are much rarer but far more dangerous, often leading to rapid hepatic necrosis and high mortality. The authors recommend routine vascular imaging when early biliary repair is being considered and advise that patients with portal vein or major hepatic artery injuries should be referred urgently to tertiary hepatopancreatobiliary centers. Conclusion The key clinical message of this review is that vasculobiliary injury should not be viewed as a simple extension of bile duct injury, but as a distinct and more dangerous entity that demands early recognition, careful vascular assessment, and specialized management. Right hepatic artery injury is the commonest pattern, whereas portal vein and major hepatic artery injuries are the most devastating. The review strongly supports delayed biliary reconstruction in selected ischemic injuries and emphasizes referral to expert centers for optimal outcomes.